OBJECTIVE: To explore the relationship between tobacco smoke exposure (reported versus biomarker) and rates of readmission for children hospitalized for asthma. METHODS: We enrolled a prospective cohort of 774 children aged 1 to 16 years admitted for asthma or bronchodilator-responsive wheezing. The primary outcome was at least 1 asthma- or wheeze-related readmission within 1 year. Caregivers reported any tobacco exposure at home, in a secondary residence, or in the car. We measured serum and saliva cotinine levels with mass spectrometry. We used logistic regression to evaluate associations between tobacco exposure and readmissions. RESULTS: A total of 619 children had complete tobacco exposure data; 57% were African American and 76% had Medicaid. Seventeen percent of children were readmitted within 1 year. Tobacco exposure rates were 35.1%, 56.1%, and 79.6% by report, serum, and saliva measures, respectively. Caregiver report of any tobacco exposure was not associated with readmission (adjusted odds ratio: 1.18; 95% confidence interval: 0.79-1.89), but having detectable serum or salivary cotinine was associated with increased odds of readmission (adjusted odds ratio [95% confidence interval]: 1.59 [1.02-2.48] and 2.35 [1.22-4.55], respectively). Among children whose caregivers reported no tobacco exposure, 39.1% had detectable serum cotinine and 69.9% had detectable salivary cotinine. Of the children with reported exposure, 87.6% had detectable serum cotinine and 97.7% had detectable salivary cotinine. CONCLUSIONS: Detectable serum and salivary cotinine levels were common among children admitted for asthma and were associated with readmission, whereas caregiver report of tobacco exposure was not.
OBJECTIVE: To explore the relationship between tobacco smoke exposure (reported versus biomarker) and rates of readmission for children hospitalized for asthma. METHODS: We enrolled a prospective cohort of 774 children aged 1 to 16 years admitted for asthma or bronchodilator-responsive wheezing. The primary outcome was at least 1 asthma- or wheeze-related readmission within 1 year. Caregivers reported any tobacco exposure at home, in a secondary residence, or in the car. We measured serum and saliva cotinine levels with mass spectrometry. We used logistic regression to evaluate associations between tobacco exposure and readmissions. RESULTS: A total of 619 children had complete tobacco exposure data; 57% were African American and 76% had Medicaid. Seventeen percent of children were readmitted within 1 year. Tobacco exposure rates were 35.1%, 56.1%, and 79.6% by report, serum, and saliva measures, respectively. Caregiver report of any tobacco exposure was not associated with readmission (adjusted odds ratio: 1.18; 95% confidence interval: 0.79-1.89), but having detectable serum or salivary cotinine was associated with increased odds of readmission (adjusted odds ratio [95% confidence interval]: 1.59 [1.02-2.48] and 2.35 [1.22-4.55], respectively). Among children whose caregivers reported no tobacco exposure, 39.1% had detectable serum cotinine and 69.9% had detectable salivary cotinine. Of the children with reported exposure, 87.6% had detectable serum cotinine and 97.7% had detectable salivary cotinine. CONCLUSIONS: Detectable serum and salivary cotinine levels were common among children admitted for asthma and were associated with readmission, whereas caregiver report of tobacco exposure was not.
Authors: R P Stankus; P K Menon; R J Rando; H Glindmeyer; J E Salvaggio; S B Lehrer Journal: J Allergy Clin Immunol Date: 1988-09 Impact factor: 10.793
Authors: Jonathan P Winickoff; Erica A Healey; Susan Regan; Elyse R Park; Clare Cole; Joan Friebely; Nancy A Rigotti Journal: Pediatrics Date: 2010-02-01 Impact factor: 7.124
Authors: Sarah K Himes; Laura R Stroud; Karl B Scheidweiler; Raymond S Niaura; Marilyn A Huestis Journal: J Pediatr Date: 2012-12-01 Impact factor: 4.406
Authors: R S Caraballo; G A Giovino; T F Pechacek; P D Mowery; P A Richter; W J Strauss; D J Sharp; M P Eriksen; J L Pirkle; K R Maurer Journal: JAMA Date: 1998-07-08 Impact factor: 56.272
Authors: Jonathan P Winickoff; Valerie J Hillis; Judith S Palfrey; James M Perrin; Nancy A Rigotti Journal: Pediatrics Date: 2003-01 Impact factor: 7.124
Authors: Brian P Jenssen; Eric D Shelov; Christopher P Bonafide; Steven L Bernstein; Alexander G Fiks; Tyra Bryant-Stephens Journal: Appl Clin Inform Date: 2016-05-25 Impact factor: 2.342
Authors: Katherine C Wai; Anna M Hibbs; Martina A Steurer; Dennis M Black; Jeanette M Asselin; Eric C Eichenwald; Philip L Ballard; Roberta A Ballard; Roberta L Keller Journal: J Pediatr Date: 2018-04-04 Impact factor: 4.406
Authors: Adam J Spanier; Andrew F Beck; Bin Huang; Meghan E McGrady; Dennis D Drotar; Roy W A Peake; Mark D Kellogg; Robert S Kahn Journal: Pediatrics Date: 2015-01-12 Impact factor: 7.124
Authors: Andrew F Beck; Bin Huang; Katherine A Auger; Patrick H Ryan; Chen Chen; Robert S Kahn Journal: JAMA Pediatr Date: 2016-07-01 Impact factor: 16.193